Global Heparin Market Gears Up for a 5% Growth Journey to 2026

Heparin market is driven by factors like chronic diseases, geriatric population, anticoagulant demand, heparin use in surgeries, and availability of synthetic and semi-synthetic heparin mimetics.
BRUSSELS - Oct. 27, 2023 - PRLog -- Heparin is a prescription injectable anticoagulant used to treat and prevent the symptoms of blood clots caused by medical disorders or medical treatments. It's also utilized to make an anti-clotting surface within medical devices like dialysis machines and test tubes.

Heparin is being more widely used in a variety of applications. What is driving the growth of the heparin market?

Anticoagulants act by reducing the ability of the blood to clot. It aids in the prevention of clot formation as well as the prevention of additional clot enlargement. As a result, it can be employed in a variety of applications.

The use of low molecular weight unfractionated heparin instead of heparin to prevent deep vein thrombosis or pulmonary embolism is increasing. Increases Demand

Low-molecular-weight heparins have significant advantages over UFH, leading to their increased use for thromboembolic indications such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). LMWH outperforms heparin in terms of bioavailability and half-life, easier dose, predictable anticoagulant response, lesser risk of heparin-induced thrombocytopenia (HIT), and lower risk of osteoporosis.

North America has the largest market share, but APAC is expected to grow the fastest in the heparin market.

The heparin market is dominated by North America, followed by Europe and Asia Pacific. This is mostly due to the region's high chronic disease burden, the presence of advanced and robust healthcare infrastructure, rising need for heparin in various procedures, and rising occurrences of cardiovascular ailments. However, Asia-Pacific is expected to grow significantly during the forecast period due to the region's position as the largest supplier base of crude heparin, the rising incidence of venous thromboembolism and cardiovascular diseases, an increase in surgical procedures, and an increase in the geriatric population.

Competitive Landscape Analysis: Heparin Market

The global heparin market is marked by the presence of established market players such as Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., and Fresenius SE & Co KGaA among others.

Get Detailed Insights on Heparin Market with TOC and a Sample Report PDF @

Ruta Halde
Source: » Follow
Posted By:*** Email Verified
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-tech Insights News
Most Viewed
Daily News

Like PRLog?
Click to Share